News

October 7, 2019

October 7 is the birth date of Danish physicist Niels Bohr [1] (1885-1862). Bohr has a special significance for Alpha Tau, for two reasons. The first reason is because he was one of the key contributors to the foundational discoveries in atomic physics at the beginning...

October 2, 2019

"It is my honor to assume the duty of Chief Scientific Officer of ATM," said Prof. Keisari, "our alpha radiation-based brachytherapy has already demonstrated its potential to treat tumorous lesions in humans, and I see it as my mission to take this treat...

September 4, 2019

Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy Alpha DaRT, announced today the appointment of Dr. Robert B. Den, MD, as Chief Medical Officer (CMO). In his new role, and as a prominent expert and accomplished clinician, Dr. Den will lea...

July 2, 2019

Dear Colleagues and Friends, 

I am thrilled to share with you our newest developments achieved in the past months - whether it comes to new collaborations, approvals, research or operational developments, Alpha Tau is rapidly progressing!

In the last several weeks, we ha...

June 18, 2019

We're excited that at this year’s American Brachytherapy Society (ABS) Meeting, Prof. Keisari was awarded the Best Oral Presentation Award at the Breast Plenary Session!

Prof. Keisari presented his results on “Immunomodulation of the Antitumor Response Induced by Alpha...

April 11, 2019

Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that it has obtained ISO 13485:2016 certification. The certification was awarded following an audit by the UK's independent national compliance body, British St...

March 26, 2019

Tel Aviv, Israel, March 26, 2019 – Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that Mr. Raphi Levy will be joining Alpha Tau’s management team as Chief Financial Officer. Mr. Levy will focus primarily on...

February 19, 2019

We are delighted to share with you our first quarterly newsletter of 2019. 

Beyond the great operational progress, our most important advancement this quarter has been the highly promising clinical results from the cancer centers, Rabin Medical Center (RMC) in Israel...

January 31, 2019

Radiation therapy, the use of high-energy particles or waves, such as x-rays, gamma rays, electrons, or protons, has long been used to treat cancer. From as early as the 20th Century, physicians have given regular doses of radiation to greatly improve the patient’s cha...

January 14, 2019

10 companies were selected under the healthcare category and 4 were from Israel, including Alpha Tau Medical.

Please reload

Categories
Please reload

Sign up
Featured Posts